Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography
Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to d...
Saved in:
Published in | European Heart Journal Vol. 28; no. 8; pp. 961 - 967 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.04.2007
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
ISSN | 0195-668X 1522-9645 |
DOI | 10.1093/eurheartj/ehl413 |
Cover
Abstract | Aims
Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima.
Methods and results
A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 µm (28.0 µm, 147.6 µm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap.
Conclusion
At 6 months, most of the SES were covered with thin neointima, but few showed full coverage. |
---|---|
AbstractList | Aims
Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima.
Methods and results
A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 µm (28.0 µm, 147.6 µm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap.
Conclusion
At 6 months, most of the SES were covered with thin neointima, but few showed full coverage. Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima.AIMSSince the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima.A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 microm (28.0 microm, 147.6 microm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap.METHODS AND RESULTSA total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 microm (28.0 microm, 147.6 microm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap.At 6 months, most of the SES were covered with thin neointima, but few showed full coverage.CONCLUSIONAt 6 months, most of the SES were covered with thin neointima, but few showed full coverage. Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima. A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 microm (28.0 microm, 147.6 microm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap. At 6 months, most of the SES were covered with thin neointima, but few showed full coverage. Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still controversial to what extent SES remain uncovered. However, optical coherence tomography (OCT) with excellent resolution may be able to detect thinner neointima. Methods and results A total of 34 patients (57 SES) underwent OCT and IVUS evaluations at 6-month follow-up. The thickness of neointima on each SES strut cross-section and strut apposition to the vessel wall was evaluated. By OCT evaluation, the median (25th, 75th percentiles) neointima thickness was 52.5 µm (28.0 µm, 147.6 µm) and the prevalence of struts covered by thin neointima undetectable by IVUS was 64%. The average rate of neointima-covered struts in an individual SES was 89%. Nine SES (16%) showed full coverage by neointima, whereas the remaining stents had partially uncovered strut lesions. Among the 6840 struts visualized by OCT in all of the SES, 79 struts showed malapposition without neointimal coverage, and were frequently observed in the areas of SES overlap. Conclusion At 6 months, most of the SES were covered with thin neointima, but few showed full coverage. |
Author | Hirata Ken-ichi Yokoyama Mitsuhiro Otake Hiromasa Sawada Takahiro Tanino Yusuke Oscar Luis Paredes Matsumoto Daisuke Shinke Toshiro Ogasawara Daisuke Shite Junya |
Author_xml | – sequence: 1 givenname: Daisuke surname: Matsumoto fullname: Matsumoto, Daisuke organization: Kobe University Graduate School of Medicine – sequence: 2 givenname: Junya surname: Shite fullname: Shite, Junya email: shite@med.kobe-u.ac.jp organization: Kobe University Graduate School of Medicine – sequence: 3 givenname: Toshiro surname: Shinke fullname: Shinke, Toshiro organization: Kobe University Graduate School of Medicine – sequence: 4 givenname: Hiromasa surname: Otake fullname: Otake, Hiromasa organization: Kobe University Graduate School of Medicine – sequence: 5 givenname: Yusuke surname: Tanino fullname: Tanino, Yusuke organization: Kobe University Graduate School of Medicine – sequence: 6 givenname: Daisuke surname: Ogasawara fullname: Ogasawara, Daisuke organization: Kobe University Graduate School of Medicine – sequence: 7 givenname: Takahiro surname: Sawada fullname: Sawada, Takahiro organization: Kobe University Graduate School of Medicine – sequence: 8 givenname: Oscar Luis surname: Paredes fullname: Paredes, Oscar Luis organization: Kobe University Graduate School of Medicine – sequence: 9 givenname: Ken-ichi surname: Hirata fullname: Hirata, Ken-ichi organization: Kobe University Graduate School of Medicine – sequence: 10 givenname: Mitsuhiro surname: Yokoyama fullname: Yokoyama, Mitsuhiro organization: Kobe University Graduate School of Medicine |
BackLink | https://cir.nii.ac.jp/crid/1570009752590953216$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/17135281$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1v1DAQxS1URLeFOydkIcQFhfojduzeUMWXVMEFJG6R453seuXYwXaK9r_HJQWkHhCXmcvvzYzemzN0EmIAhJ5S8poSzS9gSXswqRwuYO9byh-gDRWMNVq24gRtCNWikVJ9O0VnOR8IIUpS-Qid0o5ywRTdoPgJogvFTcZjG28gmR3gOOLsUvRuWnIDfiku7HAuEErGpmDZTDGUPR6j9_FHs8yXGG6MX0yBLR6OOM7F2V_z9pAgWMAlTnGXzLw_PkYPR-MzPLnr5-jru7dfrj4015_ff7x6c91Y0dLScN4pY5VglgzcdkQKLQTvmLQKmFWEiK5TmgCVvBuMbreDGdqWgBDKbvmo-Dl6uc6dU_y-QC795LIF702AuOS-Iy1pNRMVfH4PPMQlhXpbz6gQtGWcVujZHbQME2z7OVXD0rH_7WMFyArYFHNOMP5FSH8bVf8nqn6NqkrkPYl1xRRXrU3G-X8JX63CuMz_s-bFSgfn6obbSkVXX0F3gglNtOCsuvgTEI222Q |
CitedBy_id | crossref_primary_10_1007_s10554_009_9508_4 crossref_primary_10_4244_EIJ_D_20_01162 crossref_primary_10_4244_EIJV5I1A14 crossref_primary_10_1007_s00392_010_0163_5 crossref_primary_10_1536_ihj_20_627 crossref_primary_10_1016_j_jacc_2014_01_019 crossref_primary_10_1177_1358863X08095153 crossref_primary_10_1016_j_jjcc_2014_07_003 crossref_primary_10_1016_j_zemedi_2009_11_002 crossref_primary_10_1161_CIRCULATIONAHA_107_762096 crossref_primary_10_4244_EIJY15M12_05 crossref_primary_10_1016_j_ijcard_2009_04_039 crossref_primary_10_1016_j_ijcard_2010_11_006 crossref_primary_10_1253_circj_CJ_13_1540 crossref_primary_10_1016_j_jcmg_2011_03_014 crossref_primary_10_4244_EIJV3I5A104 crossref_primary_10_1007_s00380_021_01889_w crossref_primary_10_2217_ica_09_29 crossref_primary_10_1093_eurheartj_ehq458 crossref_primary_10_1186_1476_7120_9_2 crossref_primary_10_1016_j_jjcc_2013_10_020 crossref_primary_10_1177_1526602815610116 crossref_primary_10_1016_j_ijcard_2009_07_012 crossref_primary_10_1002_ccd_24327 crossref_primary_10_1093_eurheartj_ehp480 crossref_primary_10_1007_s10554_011_0007_z crossref_primary_10_1016_j_amjcard_2009_01_378 crossref_primary_10_1016_j_jcmg_2009_09_018 crossref_primary_10_1016_j_carrev_2008_11_003 crossref_primary_10_1016_j_jcin_2008_01_004 crossref_primary_10_4244_EIJV7I4A80 crossref_primary_10_1007_s10554_012_0046_0 crossref_primary_10_1007_s10554_019_01636_3 crossref_primary_10_2217_ica_09_37 crossref_primary_10_1016_j_jcin_2009_12_015 crossref_primary_10_1253_circj_CJ_09_0859 crossref_primary_10_4244_EIJV5I5A89 crossref_primary_10_1016_j_jcin_2011_08_015 crossref_primary_10_1007_s00380_013_0376_4 crossref_primary_10_1093_ehjci_jev108 crossref_primary_10_1016_j_ijcard_2020_08_016 crossref_primary_10_1007_s00059_011_3464_1 crossref_primary_10_1016_j_jcmg_2008_03_012 crossref_primary_10_1007_s10554_011_9849_7 crossref_primary_10_1016_j_ijcard_2013_10_023 crossref_primary_10_1016_j_jcin_2009_03_003 crossref_primary_10_1016_j_jcmg_2012_01_024 crossref_primary_10_1016_j_jjcc_2008_05_003 crossref_primary_10_1253_jjcsc_15_2_327 crossref_primary_10_1016_j_amjcard_2015_02_042 crossref_primary_10_1253_circj_CJ_08_1166 crossref_primary_10_1016_j_jcin_2009_03_006 crossref_primary_10_1111_j_1755_5922_2010_00187_x crossref_primary_10_1161_JAHA_119_011975 crossref_primary_10_1136_heartasia_2013_010328 crossref_primary_10_1586_erc_13_37 crossref_primary_10_1093_eurheartj_ehs095 crossref_primary_10_1016_S1885_5857_09_71847_X crossref_primary_10_33678_cor_2009_221 crossref_primary_10_1253_circj_CJ_10_1237 crossref_primary_10_1161_JAHA_120_020243 crossref_primary_10_1002_ccd_26673 crossref_primary_10_1016_j_jacl_2021_11_012 crossref_primary_10_1016_j_jconrel_2016_07_023 crossref_primary_10_1016_j_ahj_2010_06_043 crossref_primary_10_4244_EIJV6I1A62 crossref_primary_10_1186_1745_6215_13_55 crossref_primary_10_1016_j_ihj_2016_12_022 crossref_primary_10_1016_j_ijcha_2019_100382 crossref_primary_10_1161_CIRCINTERVENTIONS_108_802926 crossref_primary_10_1016_j_carrev_2014_04_005 crossref_primary_10_2217_ica_10_41 crossref_primary_10_2459_JCM_0b013e32832ffad3 crossref_primary_10_1093_ehjci_jes299 crossref_primary_10_2459_JCM_0b013e3283536b2b crossref_primary_10_4244_EIJV5I2A35 crossref_primary_10_1007_s12928_009_0006_3 crossref_primary_10_1016_j_jcin_2010_02_008 crossref_primary_10_3349_ymj_2018_59_5_624 crossref_primary_10_6009_jjrt_65_1041 crossref_primary_10_1016_j_jjcc_2018_04_005 crossref_primary_10_1253_circj_CJ_12_0190 crossref_primary_10_1016_j_jcin_2011_04_007 crossref_primary_10_1016_j_iccl_2015_02_009 crossref_primary_10_1016_j_ijcard_2021_12_008 crossref_primary_10_4244_EIJV3I3A66 crossref_primary_10_4244_EIJV9I12A232 crossref_primary_10_1016_j_carrev_2015_12_001 crossref_primary_10_1016_j_jcmg_2011_03_020 crossref_primary_10_1002_ccd_23186 crossref_primary_10_1016_j_jjcc_2011_12_003 crossref_primary_10_1016_j_plabm_2021_e00202 crossref_primary_10_1007_s12410_014_9308_7 crossref_primary_10_1016_j_ahj_2023_05_004 crossref_primary_10_1007_s12928_018_0540_y crossref_primary_10_3349_ymj_2013_54_5_1075 crossref_primary_10_2217_iim_11_24 crossref_primary_10_1016_j_jcin_2011_09_018 crossref_primary_10_1118_1_4943374 crossref_primary_10_1016_j_jcmg_2009_10_007 crossref_primary_10_47102_annals_acadmedsg_V39N3p221 crossref_primary_10_1007_s12350_009_9100_2 crossref_primary_10_1093_eurheartj_ehq168 crossref_primary_10_2169_naika_98_280 crossref_primary_10_4244_EIJV6I7A149 crossref_primary_10_2217_ica_11_34 crossref_primary_10_1016_j_ijcard_2020_01_024 crossref_primary_10_1016_S0300_8932_10_70201_3 crossref_primary_10_1016_j_ahj_2009_11_029 crossref_primary_10_1016_S1561_8811_12_80016_2 crossref_primary_10_1016_j_jcin_2015_07_017 crossref_primary_10_1161_JAHA_119_015579 crossref_primary_10_1016_j_amjcard_2008_02_091 crossref_primary_10_1186_s12933_016_0395_4 crossref_primary_10_3760_cma_j_issn_0366_6999_2010_05_014 crossref_primary_10_1016_j_ijcard_2008_05_069 crossref_primary_10_1007_s10554_018_1384_3 crossref_primary_10_2459_JCM_0b013e3283406428 crossref_primary_10_1016_j_jjcc_2016_12_011 crossref_primary_10_1161_CIRCINTERVENTIONS_115_003469 crossref_primary_10_1253_circj_CJ_09_0792 crossref_primary_10_1253_circj_CJ_08_1116 crossref_primary_10_1016_j_rbci_2015_02_001 crossref_primary_10_2459_JCM_0b013e3283403409 crossref_primary_10_4244_EIJV4I4A89 crossref_primary_10_1155_2009_816715 crossref_primary_10_1253_circj_CJ_11_1363 crossref_primary_10_1016_j_jcmg_2021_03_028 crossref_primary_10_1253_circj_CJ_11_1122 crossref_primary_10_4244_EIJY14M10_01 crossref_primary_10_1016_j_ejvs_2013_03_005 crossref_primary_10_1016_j_ijcard_2010_05_004 crossref_primary_10_4244_EIJV9I8A159 crossref_primary_10_1016_j_jcin_2009_10_031 crossref_primary_10_1016_j_jcin_2012_05_012 crossref_primary_10_1016_j_ijcard_2012_03_084 crossref_primary_10_1016_j_rbciev_2015_02_001 crossref_primary_10_1093_eurheartj_ehq066 crossref_primary_10_1007_s00380_018_1131_7 crossref_primary_10_1161_CIRCINTERVENTIONS_110_950154 crossref_primary_10_3760_cma_j_issn_0366_6999_20121485 crossref_primary_10_1177_0300985811400446 crossref_primary_10_1536_ihj_21_826 crossref_primary_10_4244_EIJV6I1A13 crossref_primary_10_1186_1757_1626_3_68 crossref_primary_10_1007_s10554_012_0031_7 crossref_primary_10_1586_14779072_2016_1112267 crossref_primary_10_1088_0031_9155_53_12_001 crossref_primary_10_1536_ihj_20_458 crossref_primary_10_1016_j_ijcard_2011_05_076 crossref_primary_10_1117_1_3290810 crossref_primary_10_1536_ihj_18_531 crossref_primary_10_1016_j_jjcc_2010_05_005 crossref_primary_10_1161_CIRCINTERVENTIONS_108_770008 crossref_primary_10_1097_MAJ_0b013e31816c7bdf crossref_primary_10_1016_j_jjcc_2015_07_014 crossref_primary_10_1093_ehjci_jes025 crossref_primary_10_4103_heartindia_heartindia_38_19 crossref_primary_10_1253_circj_CJ_10_0525 crossref_primary_10_1016_j_jcin_2010_08_006 crossref_primary_10_1016_j_amjcard_2009_03_047 crossref_primary_10_1016_j_ihj_2012_11_008 crossref_primary_10_1016_j_jjcc_2015_12_011 crossref_primary_10_2217_fca_11_59 crossref_primary_10_1002_ccd_21482 crossref_primary_10_1016_j_ijcard_2012_02_013 crossref_primary_10_1253_circj_CJ_09_0690 crossref_primary_10_1253_circj_CJ_13_1474 crossref_primary_10_1371_journal_pone_0240860 crossref_primary_10_1016_j_jcin_2007_10_004 crossref_primary_10_1007_s12928_017_0507_4 crossref_primary_10_1007_s10554_010_9729_6 crossref_primary_10_1016_S0300_8932_09_71046_2 crossref_primary_10_1016_j_amjcard_2009_11_018 crossref_primary_10_1016_j_ijcard_2014_11_068 crossref_primary_10_1016_j_amjcard_2016_03_038 crossref_primary_10_3904_kjim_2012_27_1_1 crossref_primary_10_4244_EIJ_D_19_00206 crossref_primary_10_1016_S0300_8932_10_70207_4 crossref_primary_10_1007_s11239_015_1207_5 crossref_primary_10_1016_j_jcin_2008_12_006 crossref_primary_10_1016_S1885_5857_10_70183_3 crossref_primary_10_1161_CIRCINTERVENTIONS_110_957118 crossref_primary_10_1016_j_jcin_2009_01_012 crossref_primary_10_1586_17434440_6_2_157 crossref_primary_10_2174_1874306401307010026 crossref_primary_10_1016_j_jcin_2009_01_010 crossref_primary_10_1016_j_jacl_2018_10_007 crossref_primary_10_1042_CS20180879 crossref_primary_10_1159_000357612 crossref_primary_10_1007_s10554_011_9905_3 crossref_primary_10_1093_eurheartj_ehv768 crossref_primary_10_1007_s12410_012_9138_4 crossref_primary_10_15791_angioscopy_re_17_0017 crossref_primary_10_1016_j_jbiomech_2017_09_016 crossref_primary_10_1007_s12410_009_0032_7 crossref_primary_10_1016_j_jcin_2010_04_005 crossref_primary_10_1253_circj_CJ_08_0746 crossref_primary_10_1007_s10554_011_9796_3 crossref_primary_10_1007_BF02938368 crossref_primary_10_1111_j_1540_8183_2009_00485_x crossref_primary_10_1016_j_jacc_2009_11_052 crossref_primary_10_1253_circj_CJ_09_0113 crossref_primary_10_1016_j_jacl_2023_01_004 crossref_primary_10_2217_ica_12_71 crossref_primary_10_1007_s12928_022_00877_9 crossref_primary_10_1007_s12350_009_9060_6 crossref_primary_10_1253_circj_CJ_13_0374 crossref_primary_10_1007_s11886_020_01299_w crossref_primary_10_1007_s00380_015_0728_3 crossref_primary_10_1016_j_jcin_2009_08_003 crossref_primary_10_3349_ymj_2011_52_6_1028 crossref_primary_10_1016_j_jbiomech_2013_10_048 crossref_primary_10_1007_s12928_011_0051_6 crossref_primary_10_1586_17434440_5_6_691 crossref_primary_10_1016_j_atherosclerosis_2007_12_055 crossref_primary_10_1586_17434440_6_1_33 crossref_primary_10_1002_ccd_25610 crossref_primary_10_1016_j_jcmg_2009_01_011 crossref_primary_10_1155_2012_956962 crossref_primary_10_1161_CIRCINTERVENTIONS_113_001146 crossref_primary_10_1253_circj_CJ_09_0377 crossref_primary_10_1016_j_jcin_2009_10_006 crossref_primary_10_2217_ica_13_62 crossref_primary_10_3892_mmr_2013_1313 crossref_primary_10_1016_j_cjca_2015_06_029 crossref_primary_10_1016_j_jcin_2012_09_017 crossref_primary_10_1253_circj_CJ_11_0961 crossref_primary_10_1016_j_ijcard_2008_11_204 crossref_primary_10_1093_ehjci_jet088 crossref_primary_10_1109_TMI_2009_2037755 crossref_primary_10_1016_j_acvd_2009_05_010 crossref_primary_10_1016_j_jcin_2011_03_020 crossref_primary_10_1253_circj_CJ_11_0845 crossref_primary_10_1161_CIRCINTERVENTIONS_109_868398 crossref_primary_10_1002_ccd_21606 crossref_primary_10_1016_j_jjcc_2015_06_011 crossref_primary_10_1111_j_1540_8183_2009_00458_x crossref_primary_10_4244_EIJ_D_15_00399 crossref_primary_10_1016_j_jcin_2007_11_001 crossref_primary_10_1115_1_4043866 crossref_primary_10_1016_j_ijcard_2012_10_043 crossref_primary_10_1007_s10554_013_0282_y crossref_primary_10_2217_nnm_16_3 crossref_primary_10_4244_EIJV7I3A60 crossref_primary_10_1007_s12181_007_0012_6 crossref_primary_10_1016_j_ijcard_2010_12_072 crossref_primary_10_1016_S1885_5857_10_70189_4 crossref_primary_10_1016_j_acvd_2010_12_004 crossref_primary_10_1016_j_amjcard_2008_08_057 crossref_primary_10_1016_j_cjca_2015_02_036 crossref_primary_10_1111_jon_12223 crossref_primary_10_1002_rcs_2033 crossref_primary_10_1253_circj_CJ_14_0315 crossref_primary_10_1093_ehjci_jeu188 crossref_primary_10_2217_ica_09_13 crossref_primary_10_1002_ccd_26969 crossref_primary_10_4244_EIJV11I5A109 crossref_primary_10_4244_EIJV7SKA16 crossref_primary_10_1016_j_jacc_2007_12_059 crossref_primary_10_1002_ccd_22125 crossref_primary_10_1002_ccd_23215 |
ContentType | Journal Article |
Copyright | The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2007 Copyright Oxford University Press(England) Apr 2007 |
Copyright_xml | – notice: The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2007 – notice: Copyright Oxford University Press(England) Apr 2007 |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP K9. 7X8 |
DOI | 10.1093/eurheartj/ehl413 |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | D. Matsumoto et al.SES follow-up with OCT |
EISSN | 1522-9645 |
EndPage | 967 |
ExternalDocumentID | 1261029451 17135281 10_1093_eurheartj_ehl413 10.1093/eurheartj/ehl413 120001075377 |
Genre | Journal Article |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 08P 0R~ 18M 1TH 29G 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAFWJ AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNGD ABNHQ ABNKS ABOCM ABPQP ABPTD ABQLI ABQNK ABVGC ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUKT ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGHP ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFIYH AFOFC AFXAL AFYAG AGINJ AGKEF AGORE AGQPQ AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ASPBG ATGXG AVWKF AXUDD AZFZN BAWUL BAYMD BCGUY BCRHZ BEYMZ BHONS BTRTY BVRKM C1A C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M41 MHKGH ML0 N9A NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OB3 OCZFY ODMLO OGROG OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RUSNO RW1 RXO RYH SEL TCURE TEORI TJX W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 --K .GJ 1B1 6.Y AAPGJ AASNB AAWDT ABQTQ ABSAR ABSMQ ACFRR ACMRT ACPQN ACZBC ADJQC ADRIX AEKPW AFSHK AFXEN AGKRT AGMDO AI. APJGH AQDSO AQKUS ATTQO AVNTJ BZKNY EIHJH IHE KC5 M49 MBLQV N4W NQ- O~Y QBD RIG RNI RPZ RZF TMA UHS VH1 ZGI AAYXX CITATION AEHUL AFFQV CGR CUY CVF ECM EIF NPM 7QP K9. 7X8 |
ID | FETCH-LOGICAL-c541t-3378ac852c0b3c70659553726c8e2c800577890e1637ba94dbab440e558cd3f83 |
ISSN | 0195-668X |
IngestDate | Fri Jul 11 10:03:48 EDT 2025 Sun Jun 29 16:19:45 EDT 2025 Wed Feb 19 01:47:14 EST 2025 Thu Apr 24 23:03:36 EDT 2025 Tue Jul 01 01:09:25 EDT 2025 Wed Aug 28 03:24:38 EDT 2024 Fri Jun 27 00:13:35 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Neointima Malapposition Optical coherence tomography Sirolimus-eluting stents |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c541t-3378ac852c0b3c70659553726c8e2c800577890e1637ba94dbab440e558cd3f83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://hdl.handle.net/20.500.14094/90000682 |
PMID | 17135281 |
PQID | 215514231 |
PQPubID | 29905 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_70404925 proquest_journals_215514231 pubmed_primary_17135281 crossref_primary_10_1093_eurheartj_ehl413 crossref_citationtrail_10_1093_eurheartj_ehl413 oup_primary_10_1093_eurheartj_ehl413 nii_cinii_1570009752590953216 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-04-01 |
PublicationDateYYYYMMDD | 2007-04-01 |
PublicationDate_xml | – month: 04 year: 2007 text: 2007-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | European Heart Journal |
PublicationTitleAlternate | Eur Heart J |
PublicationYear | 2007 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
References | 17347174 - Eur Heart J. 2007 Apr;28(8):918-9 |
References_xml | – reference: 17347174 - Eur Heart J. 2007 Apr;28(8):918-9 |
SSID | ssj0008616 |
Score | 2.3953621 |
Snippet | Aims
Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is... Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is still... Aims Since the intravascular ultrasound (IVUS) cannot detect neointimal layers in the majority of sirolimus-eluting stents (SES) at the chronic phase, it is... |
SourceID | proquest pubmed crossref oup nii |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 961 |
SubjectTerms | Aged Aspirin - therapeutic use Catheterization Cell Proliferation Coronary Restenosis - drug therapy Coronary Restenosis - pathology Coronary Thrombosis - pathology Drug Therapy, Combination Female Follow-Up Studies Humans Immunosuppressive Agents - administration & dosage Male Sirolimus - administration & dosage Stents Ticlopidine - therapeutic use Tomography, Optical Coherence Tunica Intima - pathology |
Title | Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography |
URI | https://cir.nii.ac.jp/crid/1570009752590953216 https://www.ncbi.nlm.nih.gov/pubmed/17135281 https://www.proquest.com/docview/215514231 https://www.proquest.com/docview/70404925 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFLa6ISEuiN-UMfBhF1SFNY4dO9wQ2qimrRxopd6CkyZqxppUiyM0_nqe7dRNVwSDixU5je36fXmxn9_7HkJHGSfDuQTtN0wI9SinwpO5n3ucEcGY5PCZ0MHJF-NwNKVnMzbr9b51vJYalbxPf_42ruR_pAp1IFcdJfsPknWNQgVcg3yhBAlDeScZj7OqKFWxNBwfMHppLQB1oVPxLJvay3TvxmBgAtmkGoQejE4tBjnIv_rhNSuTmsdSftvFaLVSLWvIoqWgVdWyS2x9246vc2KrQXfAxsKtYCYqk6QJoFXUzXcHoa_rpHxnTXkjO7Wl9RSaVNpkXjn7r5K2fgSVS1nLLUsF7zi4tMbLiHlhaFIJO-1LRAdloqNKI0vSvqPiLf1V1lybf3eprxdX1Aa0bvNpj7_Ep9Pz83hyMpvsoXuEc3OQ_3m2cQISoUmO60bWHmRDH8euh2Pb_tbCZa8silshkTs7E7NCmTxCD9utBf5ocfIY9bLyCbp_0TpPPEXVBi54DRdc5XgHLtjCBUuFW7hgB5cP2IEFJze4BQt2YMEbsDxD09OTyaeR1-bb8FJGfeUFARcyFYykwyRI9fl3xFjASZiKjKRCxy3rsOkMlvA8kRGdJzKhdJgxJtJ5kIvgOdovqzJ7ifDcZ0JSaI7QgPKAJjnsi_NhznPJM5GnfXS8nsw4bcnodU6Uq9g6RQSxm_7YTn8fvXNPrCwRyx9-ewjygYZ16esMDsMIlA-LNLki8cM-OgLJ3aGZg7Vo4_YlqmNi9hiwK-qjt-4uqGR9zibLrGrqmMOHUXN-9tELi4dNTzohJhH-q78-e4AebF6h12hfXTfZISx_VfLGIPgX9W-3vg |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neointimal+coverage+of+sirolimus-eluting+stents+at+6-month+follow-up%3A+evaluated+by+optical+coherence+tomography&rft.jtitle=European+heart+journal&rft.au=Matsumoto%2C+Daisuke&rft.au=Shite%2C+Junya&rft.au=Shinke%2C+Toshiro&rft.au=Otake%2C+Hiromasa&rft.date=2007-04-01&rft.issn=0195-668X&rft.volume=28&rft.issue=8&rft.spage=961&rft_id=info:doi/10.1093%2Feurheartj%2Fehl413&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon |